Colorectal Cancer Clinical Trials in Texas

Showing 141-160 of 228 trials

Safety and Efficacy Study of AMG 820 and Pembrolizumab Combination in Select Advanced Solid Tumor Cancer

NCT02713529

A multi-center Phase 1b/2 study testing the combination of AMG 820 and pembrolizumab in subjects with select advanced solid tumors.

Pancreatic CancerColorectal CancerNon-Small Cell Lung Cancer

AmMax Bio, Inc.117 participantsStarted Apr 2016

Atlanta, Georgia, United States • Boston, Massachusetts, United States • Boston, Massachusetts, United States +12 more locations

COMPLETEDPhase 1126 miles

A Study of PDR001 in Combination With LCL161, Everolimus or Panobinostat

NCT02890069

The purpose of this study was to combine the PDR001 checkpoint inhibitor with several agents with immunomodulatory activity to identify the doses and schedule for combination therapy and to preliminarily assess the safety, tolerability, pharmacological and clinical activity of these combinations.

Colorectal Cancer, Non-small Cell Lung Carcinoma (Adenocarcinoma), Triple Negative Breast Cancer, Renal Cell Carcinoma

Novartis Pharmaceuticals298 participantsStarted Oct 2016

Santa Monica, California, United States • Baltimore, Maryland, United States • Boston, Massachusetts, United States +22 more locations

Safety and Efficacy Study of AMG 820 and Pembrolizumab Combination in Select Advanced Solid Tumor Cancer

A Study of PDR001 in Combination With LCL161, Everolimus or Panobinostat

Colorectal Cancer Trials in Other Cities

5-Fluorouracil, Bevacizumab, and Radiation Followed by Modified FOLFOX6 and Bevacizumab in Stage II/III Rectal Cancer

Sample Collection Study for the CellMax Life Circulating Tumor Cell and Circulating Tumor DNA Platforms for the Early Detection of Colorectal Cancer and Adenomas

Study Evaluating GZ17-6.02 in Patients With Advanced Solid Tumors or in Combination With Capecitabine in Metastatic Hormone Receptor Positive Breast Cancer

Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected Cancers

EL CENTRO: Engaging Latinos in the Center of Cancer Treatment Options

A Phase 2 Study of Axalimogene Filolisbac (ADXS11-001) in Participants With Carcinoma of the Anorectal Canal

A Study of EDP1503 in Patients With Colorectal Cancer, Breast Cancer, and Checkpoint Inhibitor Relapsed Tumors

Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy

A Study to Evaluate the Safety, Tolerability, and Activity of TAK-931 in Participants With Metastatic Pancreatic Cancer, Metastatic Colorectal Cancer, and Other Advanced Solid Tumors

Fluorouracil-Uracil and Leucovorin in Treating Elderly Patients With Metastatic Colorectal Cancer

A Study of ADXS-NEO Expressing Personalized Tumor Antigens

Irinotecan Plus E7820 Versus FOLFIRI in Second-Line Therapy in Patients With Locally Advanced or Metastatic Colon or Rectal Cancer

Study of Neratinib +Trastuzumab or Neratinib + Cetuximab in Patients With KRAS/NRAS/BRAF/PIK3CA Wild-Type Metastatic Colorectal Cancer by HER2 Status

NSABP Patient Registry and Biospecimen Profiling Repository

Phase I/Ib Study of NIS793 in Combination With PDR001 in Patients With Advanced Malignancies.

Safety and Efficacy Study of Neratinib and Cetuximab to Treat Patients With Quadruple Wild-Type Metastatic Colorectal Cancer

Identification of Genes Associated With Cancer in Patients and Siblings Who Have Cancer

MGD007 Combined With MGA012 in Relapsed/Refractory Metastatic Colorectal Cancer

Other Conditions in Texas